Merit Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Buy
4,079
+302
+8% +$169K 0.01% 722
2026
Q1
$2.12M Buy
3,777
+109
+3% +$69.9K 0.02% 656
2025
Q4
$2.48M Buy
3,668
+592
+19% +$403K 0.02% 561
2025
Q3
$1.97M Sell
3,076
-3
-0.1% -$1.82K 0.02% 580
2025
Q2
$1.65M Buy
3,079
+1,185
+63% +$567K 0.02% 589
2025
Q1
$795K Buy
1,894
+1,133
+149% +$492K 0.01% 743
2024
Q4
$315K Buy
+761
New +$334K 0.01% 911

Other funds holding IDXX

Merit Financial Group's IDXX Position: Q2 2026 in Review

Merit Financial Group increased its Idexx Laboratories (IDXX) stake by 8% in Q2 2026, buying an estimated $169K and bringing the position to 4,079 shares worth $2.15M. The position accounts for 0.01% of the portfolio, ranked #722.

Merit Financial Group first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.48M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Merit Financial Group held 4,079 shares of Idexx Laboratories worth $2.15M as of Q2 2026.
  • Merit Financial Group bought 302 Idexx Laboratories shares in Q2 2026, an estimated $169K.
  • Idexx Laboratories made up 0.01% of Merit Financial Group's portfolio in Q2 2026, its #722 holding.
  • Merit Financial Group first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Merit Financial Group's Idexx Laboratories position peaked at $2.48M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.